Process for the synthesis of organic compounds

Details for Australian Patent Application No. 2006258050 (hide)

Owner Novartis AG

Inventors Abel, Stephan; Erb, Bernhard; Shieh, Wen-Chung; Meisenbach, Mark; Acemoglu, Murat; Krell, Christoph; Sclafani, Joseph; Xue, Song; Prashad, Mahavir

Agent Davies Collison Cave

Pub. Number AU-B-2006258050

PCT Pub. Number WO2006/135640

Priority 60/688,976 09.06.05 US

Filing date 7 June 2006

Wipo publication date 21 December 2006

Acceptance publication date 9 December 2010

International Classifications

C07D 233/58 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

Event Publications

6 December 2007 PCT application entered the National Phase

  PCT publication WO2006/135640 Priority application(s): WO2006/135640

9 December 2010 Application Accepted

  Published as AU-B-2006258050

7 April 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006258051-Process for the synthesis of 5- (methyl-1H-imidazol-1-yl) -3- (tri fluorome th yl) -benzeneamine

2006258049-Thixinopyrimidine and thienopyridine derivatives as FLT-3 kinase inhibitors